Free Trial

Astrana Health (ASTH) Earnings Date, Estimates & Call Transcripts

Astrana Health logo
$33.70 -1.39 (-3.96%)
(As of 12/20/2024 05:40 PM ET)

Astrana Health Latest Earnings Summary

Actual EPS
(Nov. 7)
$0.33
Consensus EPS
(Nov. 7)
$0.33

Astrana Health released Q3 2024 earnings on November 7, 2024, reporting an EPS of $0.33, which hit analysts' consensus estimates of $0.33. Quarterly revenue was reported to be $478.71 million, above the consensus estimate of $462.01 million. With a trailing EPS of $1.30 and a P/E Ratio of 25.92, Astrana Health's earnings are expected to grow 23.28% next year, from $1.16 to $1.43 per share.

Get Astrana Health Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Astrana Health and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ASTH Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ASTH Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Astrana Health Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q2 20241$0.40$0.40$0.40 
Q3 20241$0.30$0.30$0.30 
Q4 20241$0.17$0.17$0.17 
20243$0.87$0.87$0.87 
Q1 20251$0.38$0.38$0.38 
Q2 20251$0.30$0.30$0.30 
Q3 20251$0.34$0.34$0.34 
Q4 20251$0.31$0.31$0.31 
FY 20254$1.33$1.33 $1.33

Astrana Health Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/7/2024Q3 2024$0.33$0.33-$0.33$462.01M$478.71M
8/7/2024Q2 2024$0.39$0.40+$0.01$0.40$440.68M$486.30M
5/7/2024Q1 2024$0.32$0.31 -$0.01$0.31$413.84M$404.36M
2/27/2024Q4 2023$0.17$0.26+$0.09$0.26$341.17M$353.00M
11/7/2023Q3 2023$0.27$0.47+$0.20$0.47$352.80M$348.17M
8/7/2023Q2 2023$0.28$0.28-$0.28$341.10M$348.21M
Trump’s Sending THIS Crypto Higher on Purpose (Ad)

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

5/8/2023Q1 2023$0.35$0.42+$0.07$0.53$331.60M$337.24M
2/23/2023Q4 2022$0.09$0.02 -$0.07$0.10$264.40M$294.21M

Astrana Health Earnings - Frequently Asked Questions

Astrana Health (NASDAQ:ASTH) last announced its quarterly earning data on Thursday, November 7, 2024. Learn more on ASTH's earnings history.

Astrana Health issued an update on its FY 2024 earnings guidance on Thursday, November, 7th. The company provided earnings per share (EPS) guidance of 1.060-1.190 for the period, compared to the consensus estimate of 1.310. The company issued revenue guidance of $2.0 billion-$2.0 billion, compared to the consensus revenue estimate of $1.8 billion.

In the previous quarter, Astrana Health (NASDAQ:ASTH) reported $0.33 earnings per share (EPS) to hit the analysts' consensus estimate of $0.33. Learn more on analysts' earnings estimate vs. ASTH's actual earnings.

The conference call for Astrana Health's latest earnings report can be listened to online.
Listen to Conference Call

Astrana Health (NASDAQ:ASTH) has a recorded annual revenue of $1.72 billion.

Astrana Health (NASDAQ:ASTH) has a recorded net income of $60.72 million. ASTH has generated $1.30 earnings per share over the last four quarters.

Astrana Health (NASDAQ:ASTH) has a trailing price-to-earnings ratio of 25.92 and a forward price-to-earnings ratio of 29.05. The price/earnings-to-growth ratio is 1.8.

Astrana Health's earnings are expected to grow from $1.16 per share to $1.43 per share in the next year, which is a 23.28% increase.

More Earnings Resources from MarketBeat



This page (NASDAQ:ASTH) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners